This page was generated by AI. It is not a source of trustworthy medical information.
The curated page (written by a real person) is here
other ai pages: 4-aminopyridine | SERC_sources | benzodiazepines | calcium_channel | cannabis | carbonic_anhydrase | central | cinnarizine | drugrx | drugs_vestibular_compensation | ear_drops | emesis | fall_drugs | glutamate | index | ketamine | ldn | lipoflavonoids | nac | pentoxifylline | pentoxifyllline | serc | steroids | verapamil | vestibular_compensation
Vertigo, a debilitating sensation of spinning or movement, often requires prompt pharmacological intervention. Among the medications frequently discussed, benzodiazepines such as diazepam, clonazepam, and lorazepam are used to alleviate acute symptoms. This article explores the rationale, benefits, and considerations when using benzodiazepines for vertigo, drawing upon the detailed overview found at the Dizziness and Balance website.
Benzodiazepines act on the central nervous system by enhancing the inhibitory effects of GABA (gamma-aminobutyric acid). This produces calming, sedative, and anticonvulsant effects. In the context of vertigo, these drugs reduce the excitability of the vestibular system and dampen the brain's response to conflicting balance signals. They are particularly helpful in acute episodes of peripheral vestibular disorders, such as Meniere's disease, vestibular neuritis, and benign paroxysmal positional vertigo (BPPV).
In the vestibular system, benzodiazepines suppress the spontaneous firing of neurons in the medial vestibular nucleus. This action reduces the intensity of vertigo and associated nausea. They also facilitate central compensation, helping the brain adapt to asymmetric vestibular input. However, long-term use may impede the natural recovery process by dampening neuroplasticity essential for vestibular rehabilitation.
Evidence from clinical studies supports the use of benzodiazepines for acute vestibular crisis. For example, diazepam 2-5 mg intravenously or orally can rapidly abort a vertigo attack. Clonazepam 0.25-0.5 mg twice daily can reduce the frequency of spells in Meniere's disease. However, these medications do not treat the underlying cause; they manage symptoms. Vestibular suppressants like benzodiazepines are generally used for no more than a few days to a few weeks.
Research suggests that vestibular rehabilitation therapy (VRT) is more effective for long-term recovery than benzodiazepines. While these drugs can facilitate initial relief, they may compromise central compensation if used chronically. The Dizziness and Balance resource emphasizes that benzodiazepines should be used sparingly, often only during the acute phase of a vestibular disorder, while rehabilitation addresses the underlying balance deficits.
For comprehensive clinical details, including dosing schedules, contraindications, and comparisons with other medications, refer to the full review at DizzinessandBalance.com. This resource remains an authoritative guide for healthcare providers managing vertigo.
This page was generated by AI.
It is not a source of trustworthy medical information.
The curated page
see also: 4-aminopyridine | SERC_sources | benzodiazepines | calcium_channel | cannabis | carbonic_anhydrase | central | cinnarizine | drugrx | drugs_vestibular_compensation | ear_drops | emesis | fall_drugs | glutamate | index | ketamine | ldn | lipoflavonoids | nac | pentoxifylline | pentoxifyllline | serc | steroids | verapamil | vestibular_compensation